These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22946711)

  • 1. Clinical observations and outcome of ventricular tachycardia ablation in patients with left ventricular assist devices.
    Herweg B; Ilercil A; Kristof-Kuteyeva O; Rinde-Hoffman D; Caldeira C; Mangar D; Karlnosky R; Barold SS
    Pacing Clin Electrophysiol; 2012 Nov; 35(11):1377-83. PubMed ID: 22946711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices.
    Sacher F; Reichlin T; Zado ES; Field ME; Viles-Gonzalez JF; Peichl P; Ellenbogen KA; Maury P; Dukkipati SR; Picard F; Kautzner J; Barandon L; Koneru JN; Ritter P; Mahida S; Calderon J; Derval N; Denis A; Cochet H; Shepard RK; Corre J; Coffey JO; Garcia F; Hocini M; Tedrow U; Haissaguerre M; d'Avila A; Stevenson WG; Marchlinski FE; Jais P
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):592-7. PubMed ID: 25870335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of left ventricular tachycardia via transeptal approach and crossing of a mechanical mitral valve prosthesis.
    Herweg B; Ilercil A; Sheffield CD; Caldeira CC; Rinde-Hoffman D; Barold SS
    Pacing Clin Electrophysiol; 2010 Jul; 33(7):900-3. PubMed ID: 20132494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical ablation of refractory ventricular tachycardia in patients with nonischemic cardiomyopathy.
    Anter E; Hutchinson MD; Deo R; Haqqani HM; Callans DJ; Gerstenfeld EP; Garcia FC; Bala R; Lin D; Riley MP; Litt HI; Woo JY; Acker MA; Szeto WY; Zado ES; Marchlinski FE; Dixit S
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):494-500. PubMed ID: 21673018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support.
    Lü F; Eckman PM; Liao KK; Apostolidou I; John R; Chen T; Das GS; Francis GS; Lei H; Trohman RG; Benditt DG
    Int J Cardiol; 2013 Oct; 168(4):3859-65. PubMed ID: 23863501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
    Bunch TJ; Mahapatra S; Murdock D; Molden J; Weiss JP; May HT; Bair TL; Mader KM; Crandall BG; Day JD; Osborn JS; Muhlestein JB; Lappe DL; Anderson JL
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1600-6. PubMed ID: 21895727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience.
    Moss JD; Flatley EE; Beaser AD; Shin JH; Nayak HM; Upadhyay GA; Burke MC; Jeevanandam V; Uriel N; Tung R
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1412-1424. PubMed ID: 29759673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation for ventricular tachyarrhythmias in patients supported by continuous-flow left ventricular assist devices.
    Garan AR; Iyer V; Whang W; Mody KP; Yuzefpolskaya M; Colombo PC; Te-Frey R; Takayama H; Naka Y; Garan H; Jorde UP; Uriel N
    ASAIO J; 2014; 60(3):311-6. PubMed ID: 24614361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1).
    Miller MA; Dukkipati SR; Chinitz JS; Koruth JS; Mittnacht AJ; Napolitano C; d'Avila A; Reddy VY
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):151-9. PubMed ID: 23255277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of percutaneous left ventricular assist devices during ventricular tachycardia ablation.
    Bunch TJ; Mahapatra S; Madhu Reddy Y; Lakkireddy D
    Europace; 2012 Aug; 14 Suppl 2():ii26-ii32. PubMed ID: 22832915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
    Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
    J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices.
    Dandamudi G; Ghumman WS; Das MK; Miller JM
    Heart Rhythm; 2007 Sep; 4(9):1165-9. PubMed ID: 17765615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal Membrane Oxygenation for Hemodynamic Support of Ventricular Tachycardia Ablation.
    Baratto F; Pappalardo F; Oloriz T; Bisceglia C; Vergara P; Silberbauer J; Albanese N; Cireddu M; D'Angelo G; Di Prima AL; Monaco F; Paglino G; Radinovic A; Regazzoli D; Silvetti S; Trevisi N; Zangrillo A; Della Bella P
    Circ Arrhythm Electrophysiol; 2016 Dec; 9(12):. PubMed ID: 27932426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention.
    Frankel DS; Mountantonakis SE; Robinson MR; Zado ES; Callans DJ; Marchlinski FE
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1123-8. PubMed ID: 21539642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device.
    Osaki S; Alberte C; Murray MA; Brahmbhatt RD; Johnson MR; Edwards NM; Kohmoto T
    J Heart Lung Transplant; 2008 Mar; 27(3):353-6. PubMed ID: 18342761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Feasibility of Open Chest Epicardial Mapping and Ablation of Ventricular Tachycardia During the Period of Left Ventricular Assist Device Implantation.
    Patel M; Rojas F; Shabari FR; Simpson L; Cohn W; Frazier OH; Mallidi H; Cheng J; Mathuria N
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):95-101. PubMed ID: 26377813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT).
    Tung R; Josephson ME; Reddy V; Reynolds MR;
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):799-803. PubMed ID: 20132389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical ablation of post-infarction ventricular tachycardia guided by mapping in sinus rhythm: long term results.
    Pirk J; Bytesnik J; Kautzner J; Peichl P; Vancura V; Lefflerova K; Skalsky I; Vinduska V
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):323-9. PubMed ID: 15296891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation.
    Piacentino V; Troupes CD; Ganapathi AM; Blue LJ; Mackensen GB; Swaminathan M; Felker GM; Stafford-Smith M; Lodge AJ; Rogers JG; Milano CA
    Ann Thorac Surg; 2011 Oct; 92(4):1414-8; discussion 1418-9. PubMed ID: 21958790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.